Mosaic ImmunoEngineering, Inc. (CPMV)

Market Cap	6.52M
Revenue (ttm)	n/a
Net Income (ttm)	-1.21M
Shares Out	7.24M
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,235
Open	0.889
Previous Close	n/a
Day's Range	0.889 - 0.900
52-Week Range	0.102 - 1.130
Beta	-1.71
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 1, 2024

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate is MIE-101 which is based on cowpea mosaic virus which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2020
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: CPMV